Results 231 to 240 of about 12,467 (245)

Ivacaftor

Reactions Weekly, 2015
openaire   +1 more source

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D- CFTR mutation and preserved spirometry: a randomised controlled trial

Lancet Respiratory Medicine,the, 2013
Jane Davies, Steve Cunningham, Carlos E Milla   +2 more
exaly  

Ivacaftor/lumacaftor/Ivacaftor/tezacaftor

Reactions Weekly
openaire   +1 more source

Ivacaftor withdrawal

Reactions Weekly, 2022
openaire   +1 more source

Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study

Lancet Respiratory Medicine,the, 2019
Susanna A Mccolley, Caroline A Owen, Gregory S Sawicki   +2 more
exaly  

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

New England Journal of Medicine, 2017
Anne Munck, Edward F Mckone, Cornelis K Van Der Ent   +2 more
exaly  

Elexacaftor/Ivacaftor/tezacaftor/Ivacaftor

Reactions Weekly
openaire   +1 more source

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

New England Journal of Medicine, 2018
Lucy Burr, Marcus A Mall, Edward F Mckone   +2 more
exaly  

Elexacaftor/Ivacaftor/tezacaftor/Ivacaftor/lumacaftor

Reactions Weekly
openaire   +1 more source

Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor

Clinical Infectious Diseases, 2015
Sonya L Heltshe, Nicole Mayer-Hamblett, Bonnie W Ramsey   +2 more
exaly